Immunovant Stock Investor Trims Stake, Still Bullish
Immunovant stock surged about 30% after a fund trimmed its stake by roughly $3 million. This article explains why the...
This guide compares risk profiles of index funds and bonds in retirement, helping you choose allocations that align with your comfort and goals.
28,591 articlesImmunovant stock surged about 30% after a fund trimmed its stake by roughly $3 million. This article explains why the...
Red Cat Holdings faced a sharp price move after news about a government contract came with unclear value. This articl...
A pivotal move in AI investing just happened: a memory-focused chip stock joined Nasdaq, giving investors a new way t...
A Fed official signaled no rescue for crypto amid stress, pushing Bitcoin, Ethereum, and XRP into a fresh round of vo...
Energy markets are heating up as majors chase bolt-ons and long-life assets. Here are three smaller firms primed for ...
A landmark move by the European Commission forces Meta to open WhatsApp to rival AI chatbots. The order could reshape...
Two veteran reporters clash over OpenAI’s potential IPO. One sees missteps and scope creep; the other argues leaks dr...
NVIDIA’s latest results highlight a powerful software moat and growing AI infrastructure demand, underscoring why man...
Bitcoin briefly topped $80,000 again as traders weigh whether the move signals real demand or a looming reversal. Ana...
Bitcoin faced a key test near $74,000 as geopolitical tensions intensified, and BlackRock launched its ETHB ETF, resh...
Investors are debating whether Microsoft stock is undervalued. This guide breaks down the fundamentals, growth cataly...
The AI landscape is shifting from a few hardware champions to a broad ecosystem of software, cloud, and microchips. L...